Liver Disease and Other Comorbidities in Wolcott-Rallison Syndrome: Different Phenotype and Variable Associations in a Large Cohort

Background: Wolcott-Rallison syndrome (WRS) is caused by recessive EIF2AK3 mutations and characterized by early-onset diabetes and skeletal dysplasia. Hepatic dysfunction has been reported in 60% of patients. Aims: To describe a cohort of WRS patients and discuss the pattern and management of their...

Full description

Saved in:
Bibliographic Details
Published inHormone research in paediatrics Vol. 83; no. 3; pp. 190 - 197
Main Authors Habeb, Abdelhadi M., Deeb, Asma, Johnson, Matthew, Abdullah, Mohammed, Abdulrasoul, Majidah, Al-Awneh, Hussain, Al-Maghamsi, Mohammed S.F., Al-Murshedi, Fathiya, Al-Saif, Ramlah, Al-Sinani, Siham, Ramadan, Dina, Tfayli, Hala, Flanagan, Sarah E., Ellard, Sian
Format Journal Article
LanguageEnglish
Published Basel, Switzerland S. Karger AG 01.01.2015
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background: Wolcott-Rallison syndrome (WRS) is caused by recessive EIF2AK3 mutations and characterized by early-onset diabetes and skeletal dysplasia. Hepatic dysfunction has been reported in 60% of patients. Aims: To describe a cohort of WRS patients and discuss the pattern and management of their liver disease. Methods: Detailed phenotyping and direct sequencing of EIF2AK3 gene were conducted in all patients. Results: Twenty-eight genetically confirmed patients (67% male; mean age 4.6 years) were identified. 17 different EIF2AK3 mutations were detected, of which 2 were novel. The p.S991N mutation was associated with prolonged survival and p.I650T with delayed onset. All patients presented before 25 months with diabetes with variation in the frequency and severity of 10 other features. Liver disease, first manifested as non-autoimmune hepatitis, was the commonest extra-pancreatic feature identified in 85.7% (24/28). 22/24 had at least one episode of acute hepatic failure which was the cause of death in all deceased patients (13/28). One child was treated by liver transplantation and had no liver disease and better diabetes control for the following 6 years. Conclusions: Liver disease in WRS is more frequent than previously described and carries high mortality. The first experience with liver transplantation in WRS is encouraging.
AbstractList Wolcott-Rallison syndrome (WRS) is caused by recessive EIF2AK3 mutations and characterized by early-onset diabetes and skeletal dysplasia. Hepatic dysfunction has been reported in 60% of patients. To describe a cohort of WRS patients and discuss the pattern and management of their liver disease. Detailed phenotyping and direct sequencing of EIF2AK3 gene were conducted in all patients. Twenty-eight genetically confirmed patients (67% male; mean age 4.6 years) were identified. 17 different EIF2AK3 mutations were detected, of which 2 were novel. The p.S991N mutation was associated with prolonged survival and p.I650T with delayed onset. All patients presented before 25 months with diabetes with variation in the frequency and severity of 10 other features. Liver disease, first manifested as non-autoimmune hepatitis, was the commonest extra-pancreatic feature identified in 85.7% (24/28). 22/24 had at least one episode of acute hepatic failure which was the cause of death in all deceased patients (13/28). One child was treated by liver transplantation and had no liver disease and better diabetes control for the following 6 years. Liver disease in WRS is more frequent than previously described and carries high mortality. The first experience with liver transplantation in WRS is encouraging.
Background: Wolcott-Rallison syndrome (WRS) is caused by recessive EIF2AK3 mutations and characterized by early-onset diabetes and skeletal dysplasia. Hepatic dysfunction has been reported in 60% of patients. Aims: To describe a cohort of WRS patients and discuss the pattern and management of their liver disease. Methods: Detailed phenotyping and direct sequencing of EIF2AK3 gene were conducted in all patients. Results: Twenty-eight genetically confirmed patients (67% male; mean age 4.6 years) were identified. 17 different EIF2AK3 mutations were detected, of which 2 were novel. The p.S991N mutation was associated with prolonged survival and p.I650T with delayed onset. All patients presented before 25 months with diabetes with variation in the frequency and severity of 10 other features. Liver disease, first manifested as non-autoimmune hepatitis, was the commonest extra-pancreatic feature identified in 85.7% (24/28). 22/24 had at least one episode of acute hepatic failure which was the cause of death in all deceased patients (13/28). One child was treated by liver transplantation and had no liver disease and better diabetes control for the following 6 years. Conclusions: Liver disease in WRS is more frequent than previously described and carries high mortality. The first experience with liver transplantation in WRS is encouraging. © 2015 S. Karger AG, Basel
Background: Wolcott-Rallison syndrome (WRS) is caused by recessive EIF2AK3 mutations and characterized by early-onset diabetes and skeletal dysplasia. Hepatic dysfunction has been reported in 60% of patients. Aims: To describe a cohort of WRS patients and discuss the pattern and management of their liver disease. Methods: Detailed phenotyping and direct sequencing of EIF2AK3 gene were conducted in all patients. Results: Twenty-eight genetically confirmed patients (67% male; mean age 4.6 years) were identified. 17 different EIF2AK3 mutations were detected, of which 2 were novel. The p.S991N mutation was associated with prolonged survival and p.I650T with delayed onset. All patients presented before 25 months with diabetes with variation in the frequency and severity of 10 other features. Liver disease, first manifested as non-autoimmune hepatitis, was the commonest extra-pancreatic feature identified in 85.7% (24/28). 22/24 had at least one episode of acute hepatic failure which was the cause of death in all deceased patients (13/28). One child was treated by liver transplantation and had no liver disease and better diabetes control for the following 6 years. Conclusions: Liver disease in WRS is more frequent than previously described and carries high mortality. The first experience with liver transplantation in WRS is encouraging.
BACKGROUNDWolcott-Rallison syndrome (WRS) is caused by recessive EIF2AK3 mutations and characterized by early-onset diabetes and skeletal dysplasia. Hepatic dysfunction has been reported in 60% of patients. AIMSTo describe a cohort of WRS patients and discuss the pattern and management of their liver disease. METHODSDetailed phenotyping and direct sequencing of EIF2AK3 gene were conducted in all patients. RESULTSTwenty-eight genetically confirmed patients (67% male; mean age 4.6 years) were identified. 17 different EIF2AK3 mutations were detected, of which 2 were novel. The p.S991N mutation was associated with prolonged survival and p.I650T with delayed onset. All patients presented before 25 months with diabetes with variation in the frequency and severity of 10 other features. Liver disease, first manifested as non-autoimmune hepatitis, was the commonest extra-pancreatic feature identified in 85.7% (24/28). 22/24 had at least one episode of acute hepatic failure which was the cause of death in all deceased patients (13/28). One child was treated by liver transplantation and had no liver disease and better diabetes control for the following 6 years. CONCLUSIONSLiver disease in WRS is more frequent than previously described and carries high mortality. The first experience with liver transplantation in WRS is encouraging.
Author Abdullah, Mohammed
Habeb, Abdelhadi M.
Deeb, Asma
Johnson, Matthew
Al-Murshedi, Fathiya
Flanagan, Sarah E.
Al-Saif, Ramlah
Tfayli, Hala
Ramadan, Dina
Abdulrasoul, Majidah
Al-Awneh, Hussain
Al-Maghamsi, Mohammed S.F.
Al-Sinani, Siham
Ellard, Sian
AuthorAffiliation b Endocrine and Diabetes Unit, Maternity and Children Hospital, Madinah, UK
e Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, UK
k Gastroenterology Unit, Department of Child Health, Sultan Qaboos University Hospital, Muscat, Oman
d Paediatric Endocrinology Department, Mafraq Hospital, AbuDhabi, United Arab Emirates, UK
g Paediatric Department, Kuwait University, Kuwait
i Paediatric Endocrinology Division, Queen Rania Al Abdullah Hospital for Children, KHMC, RMS, Amman, Jordan
j Genetic and Developmental Medicine Clinic, Muscat, Oman
c Paediatric Department, Maternity and Children Hospital, Dammam, Saudi Arabia, UK
l Department of Pediatrics and Adolescent Medicine, American University of Beirut Medical Center, Beirut, Lebanon
a Paediatric Department, Prince Mohammed bin-Abdulaziz Hospital, Madinah, UK
f Paediatric Department, Khartoum University, Khartoum, Sudan
h Paediatric Department, Sabah Hospital, Kuwait
AuthorAffiliation_xml – name: i Paediatric Endocrinology Division, Queen Rania Al Abdullah Hospital for Children, KHMC, RMS, Amman, Jordan
– name: g Paediatric Department, Kuwait University, Kuwait
– name: e Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, UK
– name: l Department of Pediatrics and Adolescent Medicine, American University of Beirut Medical Center, Beirut, Lebanon
– name: j Genetic and Developmental Medicine Clinic, Muscat, Oman
– name: a Paediatric Department, Prince Mohammed bin-Abdulaziz Hospital, Madinah, UK
– name: k Gastroenterology Unit, Department of Child Health, Sultan Qaboos University Hospital, Muscat, Oman
– name: b Endocrine and Diabetes Unit, Maternity and Children Hospital, Madinah, UK
– name: d Paediatric Endocrinology Department, Mafraq Hospital, AbuDhabi, United Arab Emirates, UK
– name: h Paediatric Department, Sabah Hospital, Kuwait
– name: c Paediatric Department, Maternity and Children Hospital, Dammam, Saudi Arabia, UK
– name: f Paediatric Department, Khartoum University, Khartoum, Sudan
Author_xml – sequence: 1
  givenname: Abdelhadi M.
  surname: Habeb
  fullname: Habeb, Abdelhadi M.
  email: amhabeb@hotmail.com
– sequence: 2
  givenname: Asma
  surname: Deeb
  fullname: Deeb, Asma
– sequence: 3
  givenname: Matthew
  surname: Johnson
  fullname: Johnson, Matthew
– sequence: 4
  givenname: Mohammed
  orcidid: 0000-0001-7121-8216
  surname: Abdullah
  fullname: Abdullah, Mohammed
– sequence: 5
  givenname: Majidah
  surname: Abdulrasoul
  fullname: Abdulrasoul, Majidah
– sequence: 6
  givenname: Hussain
  surname: Al-Awneh
  fullname: Al-Awneh, Hussain
– sequence: 7
  givenname: Mohammed S.F.
  surname: Al-Maghamsi
  fullname: Al-Maghamsi, Mohammed S.F.
– sequence: 8
  givenname: Fathiya
  surname: Al-Murshedi
  fullname: Al-Murshedi, Fathiya
– sequence: 9
  givenname: Ramlah
  surname: Al-Saif
  fullname: Al-Saif, Ramlah
– sequence: 10
  givenname: Siham
  surname: Al-Sinani
  fullname: Al-Sinani, Siham
– sequence: 11
  givenname: Dina
  surname: Ramadan
  fullname: Ramadan, Dina
– sequence: 12
  givenname: Hala
  surname: Tfayli
  fullname: Tfayli, Hala
– sequence: 13
  givenname: Sarah E.
  orcidid: 0000-0002-8670-6340
  surname: Flanagan
  fullname: Flanagan, Sarah E.
– sequence: 14
  givenname: Sian
  surname: Ellard
  fullname: Ellard, Sian
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25659842$$D View this record in MEDLINE/PubMed
BookMark eNpdkUuPFCEUhYkZ4zychXtjSNzoohQKioJZmEx6fCWdjPG5rAB1a5qxClqgJ-m1f1zabivqihv47rmHe07RkQ8eEHpEyQtKG_WSEMKEkoTfQydUCFbVshZHc03lMTpP6ZbsONkq2j5Ax3UjGiV5fYJ-Lt0dRHzlEugEWPseX-dVuVmEKUTjepcdJOw8_hZGG3KuPupxdCl4_Gnr-xgmuCjdwwARfMYfVuBD3q73Sl91dNqMgC9TCtbp7IL_raXxUscbKENWIeaH6P6gxwTnh_MMfXnz-vPiXbW8fvt-cbmsbCNIrrgW0hgN_aBabigbmAQBhg8MhLVWMtJT0RpoLTEtI0Lw1rRSaGmlbkwD7Ay92uuuN2aC3hbDUY_dOrpJx20XtOv-ffFu1d2Eu45zwQmvi8Czg0AMPzaQcje5ZGEctYewSV0Zz5WoKWcFffofehs20ZfvFUoqIYgiqlDP95SNIaUIw2yGkm6XbjenW9gnf7ufyT9ZFuDxHvi-222cgUP_L9kJrCo
CitedBy_id crossref_primary_10_1055_s_0043_57005
crossref_primary_10_1111_pedi_13426
crossref_primary_10_1111_petr_13082
crossref_primary_10_1155_2024_2032425
crossref_primary_10_6065_apem_2142184_092
crossref_primary_10_1002_jimd_12733
crossref_primary_10_1002_wrna_1689
crossref_primary_10_1111_liv_15834
crossref_primary_10_4103_ipcares_ipcares_206_22
crossref_primary_10_1002_mgg3_753
crossref_primary_10_1111_cga_12217
crossref_primary_10_1002_ccr3_2168
crossref_primary_10_1007_s13312_019_1688_y
crossref_primary_10_3390_pediatric15040056
crossref_primary_10_1002_ajmg_a_37419
crossref_primary_10_1007_s12098_024_05172_4
crossref_primary_10_1530_EDM_17_0090
crossref_primary_10_1159_000512247
crossref_primary_10_1186_s13023_020_01359_y
crossref_primary_10_1016_j_jcjd_2017_06_009
crossref_primary_10_1097_HCM_0000000000000238
crossref_primary_10_1002_lt_24402
crossref_primary_10_1007_s00467_023_06254_9
crossref_primary_10_1136_bcr_2021_242376
crossref_primary_10_1186_s12881_020_0985_6
crossref_primary_10_1097_MEG_0000000000002499
crossref_primary_10_1097_TP_0000000000002869
crossref_primary_10_14341_DM8770
Cites_doi 10.1210/jc.2009-1137
10.1002/ajmg.10495
10.1038/78085
10.1136/jmg.40.9.685
10.1016/S0022-3476(72)80596-1
10.2337/diabetes.53.7.1876
10.1097/00019605-199507000-00006
10.1128/MCB.22.11.3864-3874.2002
10.1080/08035250410029362
10.1016/j.jhep.2013.04.004
10.1136/archdischild-2012-301744
10.1515/jpem-2012-0071
10.1007/BF00441137
10.3402/ljm.v8i0.21137
10.1016/S1097-2765(01)00264-7
10.1186/1750-1172-5-29
10.1007/s00431-013-2189-y
10.1097/MPG.0b013e3181623279
10.1016/j.cmet.2006.11.002
10.1007/s10545-008-0867-0
10.1111/j.1399-5448.2009.00591.x
10.1111/pedi.12089
10.1111/j.1399-5448.2011.00828.x
10.1007/s00431-013-2110-8
ContentType Journal Article
Copyright 2015 S. Karger AG, Basel
2015 S. Karger AG, Basel.
Copyright (c) 2015 S. Karger AG, Basel
Copyright © 2015 by S. Karger AG, Basel 2015
Copyright_xml – notice: 2015 S. Karger AG, Basel
– notice: 2015 S. Karger AG, Basel.
– notice: Copyright (c) 2015 S. Karger AG, Basel
– notice: Copyright © 2015 by S. Karger AG, Basel 2015
DBID M--
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7RV
7U7
7X7
7XB
88E
8AO
8FD
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
C1K
CCPQU
FR3
FYUFA
GHDGH
K9-
K9.
KB0
M0R
M0S
M1P
NAPCQ
P64
PQEST
PQQKQ
PQUKI
PRINS
RC3
7X8
5PM
DOI 10.1159/000369804
DatabaseName Karger Open Access
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
Proquest Nursing & Allied Health Source
Toxicology Abstracts
Health & Medicine (ProQuest)
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Technology Research Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
AUTh Library subscriptions: ProQuest Central
Environmental Sciences and Pollution Management
ProQuest One Community College
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
Consumer Health Database
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Family Health Database (ProQuest)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Nursing & Allied Health Premium
Biotechnology and BioEngineering Abstracts
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Technology Research Database
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Pharma Collection
ProQuest Family Health (Alumni Edition)
ProQuest Central China
Environmental Sciences and Pollution Management
ProQuest Central
Genetics Abstracts
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Medical Library (Alumni)
Toxicology Abstracts
ProQuest Family Health
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
Engineering Research Database
ProQuest One Academic
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE
Technology Research Database
CrossRef
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: M--
  name: Karger Open Access
  url: https://www.karger.com/OpenAccess
  sourceTypes: Publisher
– sequence: 4
  dbid: BENPR
  name: AUTh Library subscriptions: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 1663-2826
EndPage 197
ExternalDocumentID 3719154221
10_1159_000369804
25659842
369804
Genre Multicenter Study
Clinical Trial
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: Wellcome Trust
  grantid: 098395
– fundername: Wellcome Trust
GroupedDBID ---
0R~
0~5
0~B
30W
327
3O.
3V.
4.4
53G
7RV
7X7
88E
8AO
8FI
8FJ
AAYIC
ABJNI
ABPAZ
ABUWG
ACGFS
ACPRK
ACPSR
ADBBV
AENEX
AEYAO
AFJJK
AFKRA
AFRAH
AHMBA
ALDHI
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AZPMC
AZQEC
BENPR
BKEYQ
BKNYI
BPHCQ
BVXVI
CAG
CCPQU
COF
CYUIP
DU5
E0A
EBS
EJD
EMOBN
EX3
F5P
FB.
FYUFA
HMCUK
HZ~
IY7
K9-
KUZGX
M--
M0R
M1P
NAPCQ
O1H
O9-
OVD
PQQKQ
PROAC
PSQYO
RKO
RXVBD
SV3
TEORI
UJ6
UKHRP
WOW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7U7
7XB
8FD
8FK
C1K
FR3
K9.
P64
PQEST
PQUKI
PRINS
RC3
7X8
5PM
ID FETCH-LOGICAL-c560t-4a68bbaedf974b13f38e6eb4f3e6ccc830d167be7c0b7306647b786a8c8a5b5e3
IEDL.DBID M--
ISSN 1663-2818
IngestDate Tue Sep 17 21:25:51 EDT 2024
Fri Jun 28 09:37:20 EDT 2024
Thu Oct 10 22:08:38 EDT 2024
Fri Aug 23 02:20:19 EDT 2024
Sat Sep 28 08:11:18 EDT 2024
Thu Aug 29 12:04:35 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords Hepatitis
EIF2AK3 mutations
Skeletal dysplasia
Childhood diabetes
Liver transplantation
Language English
License applicable to the online version of the article only.
Open Access License: This is an Open Access article licensed under the terms of the Creative Commons Attribution 3.0 Unported license (CC BY 3.0)
2015 S. Karger AG, Basel.
This is an Open Access article licensed under the terms of the Creative Commons Attribution 3.0 Unported license (CC BY 3.0) (www.karger.com/OA-license-WT), applicable to the online version of the article only. Users may download, print and share this work on the Internet, provided the original work is properly cited, and a link to the original work on http://www.karger.com and the terms of this license are included in any shared versions.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c560t-4a68bbaedf974b13f38e6eb4f3e6ccc830d167be7c0b7306647b786a8c8a5b5e3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ORCID 0000-0002-8670-6340
0000-0001-7121-8216
OpenAccessLink https://karger.com/doi/10.1159/000369804
PMID 25659842
PQID 1689660909
PQPubID 1356340
PageCount 8
ParticipantIDs proquest_journals_1689660909
proquest_miscellaneous_1674962143
pubmedcentral_primary_oai_pubmedcentral_nih_gov_4464042
karger_primary_369804
pubmed_primary_25659842
crossref_primary_10_1159_000369804
PublicationCentury 2000
PublicationDate 2015-01-01
PublicationDateYYYYMMDD 2015-01-01
PublicationDate_xml – month: 01
  year: 2015
  text: 2015-01-01
  day: 01
PublicationDecade 2010
PublicationPlace Basel, Switzerland
PublicationPlace_xml – name: Basel, Switzerland
– name: Switzerland
– name: Basel
– name: Allschwilerstrasse 10, P.O. Box · Postfach · Case postale, CH–4009, Basel, Switzerland · Schweiz · Suisse, Phone: +41 61 306 11 11, Fax: +41 61 306 12 34, karger@karger.ch
PublicationTitle Hormone research in paediatrics
PublicationTitleAlternate Horm Res Paediatr
PublicationYear 2015
Publisher S. Karger AG
Publisher_xml – name: S. Karger AG
References AL-Shawi M, Al-Mutair A, Ellard S, Habeb AM: Variable phenotype in 5 patients with WRS due to the same mutation. J Pediatr Endocrinol Metab 2013;26:757-760.2358517310.1515/jpem-2012-0071
Bin-Abbas B, Al-Mulhim A, Al-Ashwal A: Wolcott Rallison syndrome in two siblings with isolated central hypothyroidism. Am J Med Genet 2002;111:187-219.1221034810.1002/ajmg.10495
Zhang W, Feng D, Li Y, Iida K, McGrath B, Cavener DR: PERK EIF2AK3 control of pancreatic beta cell differentiation and proliferation is required for postnatal glucose homeostasis. Cell Metab 2006;4:491-497.1714163210.1016/j.cmet.2006.11.002
Senee V, Vattem KM, Delepine M, et al: Wolcott Rallison syndrome: clinical, genetic, and functional study of EIF2AK3 mutations and suggestion of genetic heterogeneity. Diabetes 2004;53:1876-1883.1522021310.2337/diabetes.53.7.1876
Delepine M, Nicolino M, Barrett T, Golamaully M, Lathrop GM, Julier C: EIF2AK3, encoding translation initiation factor 2-alpha kinase 3, is mutated in patients with Wolcott Rallison syndrome. Nat Genet 2000;25:406-409.1093218310.1038/78085
Spehar Uroić A, Mulliqi Kotori V, Rojnić Putarek N, Kušec V, Dumić M: Primary hypothyroidism and nipple hypoplasia in a girl with Wolcott-Rallison syndrome. Eur J Pediatr 2014;173:529-531.2419429410.1007/s00431-013-2189-y
Scheenstra R, Gerver WJ, Odink R, et al: Growth and final height after liver transplantation during childhood. J Pediatr Gastroenterol Nutr 2008;47:165-171.1866486810.1097/MPG.0b013e3181623279
al-Gazali LI, Makia S, Azzam A, Hall CM: Wolcott-Rallison syndrome. Clin Dysmorphol 1995;4b:227-233.755115910.1097/00019605-199507000-00006
Stoss H, Pesch HJ, Pontz B, Otten A, Spranger J: Wolcott-Rallison syndrome: diabetes mellitus and spondyloepiphyseal dysplasia. Eur J Pediatr 1982;138:120-129.709493110.1007/BF00441137
Harding HP, Zeng H, Zhang Y, et al: Diabetes mellitus and exocrine pancreatic dysfunction in perk/mice reveals a role for translational control in secretory cell survival. Mol Cell 2001;7:1153-1163.1143081910.1016/S1097-2765(01)00264-7
Brickwood S, Bonthron DT, Al-Gazali LI, et al: Wolcott-Rallison syndrome: pathogenic insights into neonatal diabetes from new mutation and expression studies of EIF2AK3smutation and expression studies of EIF2AK3. J Med Genet 2003;40:685-689.1296021510.1136/jmg.40.9.685
Engelmann G, Meyburg J, Shahbek N, et al: Recurrent acute liver failure and mitochondriopathy in a case of Wolcott-Rallison syndrome. J Inherit Metab Dis 2008;31:540-546.1870476410.1007/s10545-008-0867-0
Iyer S, Korada M, Rainbow L, et al: Wolcott-Rallison syndrome: a clinical and genetic study of three children, novel mutation in EIF2AK3 and a review of the literature. Acta Paediatr 2004;93:1195-1201.1538488310.1080/08035250410029362
Habeb AM: Frequency and spectrum of Wolcott-Rallison syndrome in Saudi Arabia: a systematic review. Libyan J Med 2013;8:21137.2375935810.3402/ljm.v8i0.21137
Fagiuoli S, Daina E, D'Antiga L, Colledan M, Remuzzi G: Monogenic diseases that can be cured by liver transplantation. J Hepatol 2013;59:595-612.2357888510.1016/j.jhep.2013.04.004
Wolcott CD, Rallison ML: Infancy-onset diabetes mellitus and multiple epiphyseal dysplasia. J Pediatr 1972;80:292-297.500882810.1016/S0022-3476(72)80596-1
Zhang P, McGrath B, Li S, et al: The PERK eukaryotic initiation factor 2 alpha kinase is required for the development of the skeletal system, postnatal growth, and the function and viability of the pancreas. Mol Cell Biol 2002;22:3864-3874.1199752010.1128/MCB.22.11.3864-3874.2002
Bin-Abbas B, Shabib S, Hainau B, Al-Ashwal A: Wolcott-Rallison syndrome: clinical, radiological and histological findings in a Saudi child. Ann Saudi Med 2001;21:73-74.17264596
http://abcnews.go.com/Health/multiple-organ-transplant-terminally-ill-girl-lease-life/story?id=15877376 (last accessed on 2/9/ 2014).
Habeb AM, Al-Magamsi MSF, Eid I, et al: Incidence, genetics and clinical phenotype of permanent neonatal diabetes in northwest Saudi Arabia. Pediatr Diabetes 2012;13:499-505.2206063110.1111/j.1399-5448.2011.00828.x
Ozbek MN, Sene'e V, Aydemir S: Wolcott Rallison syndrome due to the same mutation (W522X) in EIF2AK3 in two unrelated families and review of the literature. Pediatr Diabetes 2010;11:279-285.2020214810.1111/j.1399-5448.2009.00591.x
Rubio-Cabezas O, Patch AM, et al: Wolcott Rallison syndrome is the most common genetic cause of permanent neonatal diabetes in consanguineous families. J Clin Endocrinol Metab 2009;94:4162-4170.1983791710.1210/jc.2009-1137
Jahnavi S, Poovazhagi V, Kanthimathi S, Gayathri V, Mohan V, Radha V: EIF2AK3 mutations in South Indian children with permanent neonatal diabetes mellitus associated with Wolcott-Rallison syndrome. Pediatr Diabetes 2014;15:313-318.2416845510.1111/pedi.12089
Julier C, Nicolino M: Wolcott Rallison syndrome. Orphanet J Rare Dis 2010;5:29.2105047910.1186/1750-1172-5-29
Ersoy B, Ozhan B, Kiremitçi S, Rubio-Cabezas O, Ellard S: Primary hypothyroidism: an unusual manifestation of Wolcott-Rallison syndrome. Eur J Pediatr 2014;173:1565-1568.2393366810.1007/s00431-013-2110-8
Habeb AM, Flanagan S, Deeb A, et al: Permanent neonatal diabetes: different aetiology in Arabs compared with Europeans. Arch Dis Child 2012;97:721.2285942710.1136/archdischild-2012-301744
ref13
ref24
ref12
ref23
ref15
ref14
ref20
ref11
ref22
ref10
ref21
ref2
ref1
ref17
ref16
ref19
ref18
ref8
ref7
ref9
ref4
ref3
ref6
ref5
References_xml – ident: ref4
  doi: 10.1210/jc.2009-1137
– ident: ref7
  doi: 10.1002/ajmg.10495
– ident: ref11
  doi: 10.1038/78085
– ident: ref20
  doi: 10.1136/jmg.40.9.685
– ident: ref1
  doi: 10.1016/S0022-3476(72)80596-1
– ident: ref3
  doi: 10.2337/diabetes.53.7.1876
– ident: ref19
  doi: 10.1097/00019605-199507000-00006
– ident: ref13
  doi: 10.1128/MCB.22.11.3864-3874.2002
– ident: ref2
  doi: 10.1080/08035250410029362
– ident: ref23
  doi: 10.1016/j.jhep.2013.04.004
– ident: ref10
  doi: 10.1136/archdischild-2012-301744
– ident: ref15
  doi: 10.1515/jpem-2012-0071
– ident: ref14
  doi: 10.1007/BF00441137
– ident: ref9
  doi: 10.3402/ljm.v8i0.21137
– ident: ref12
  doi: 10.1016/S1097-2765(01)00264-7
– ident: ref8
  doi: 10.1186/1750-1172-5-29
– ident: ref17
  doi: 10.1007/s00431-013-2189-y
– ident: ref24
  doi: 10.1097/MPG.0b013e3181623279
– ident: ref21
  doi: 10.1016/j.cmet.2006.11.002
– ident: ref22
  doi: 10.1007/s10545-008-0867-0
– ident: ref5
  doi: 10.1111/j.1399-5448.2009.00591.x
– ident: ref6
  doi: 10.1111/pedi.12089
– ident: ref16
  doi: 10.1111/j.1399-5448.2011.00828.x
– ident: ref18
  doi: 10.1007/s00431-013-2110-8
SSID ssj0000387917
Score 2.290366
Snippet Background: Wolcott-Rallison syndrome (WRS) is caused by recessive EIF2AK3 mutations and characterized by early-onset diabetes and skeletal dysplasia. Hepatic...
Wolcott-Rallison syndrome (WRS) is caused by recessive EIF2AK3 mutations and characterized by early-onset diabetes and skeletal dysplasia. Hepatic dysfunction...
BACKGROUNDWolcott-Rallison syndrome (WRS) is caused by recessive EIF2AK3 mutations and characterized by early-onset diabetes and skeletal dysplasia. Hepatic...
SourceID pubmedcentral
proquest
crossref
pubmed
karger
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 190
SubjectTerms Child, Preschool
Cohort Studies
Comorbidity
Diabetes Mellitus, Type 1 - genetics
Diabetes Mellitus, Type 1 - mortality
Diabetes Mellitus, Type 1 - surgery
eIF-2 Kinase - genetics
Epiphyses - abnormalities
Epiphyses - surgery
Female
Hepatitis - genetics
Hepatitis - mortality
Hepatitis - surgery
Humans
Liver Failure - genetics
Liver Failure - mortality
Liver Failure - surgery
Liver Transplantation
Male
Mutation
Original Paper
Osteochondrodysplasias - genetics
Osteochondrodysplasias - mortality
Osteochondrodysplasias - surgery
SummonAdditionalLinks – databaseName: AUTh Library subscriptions: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwEB5By4ELAlogUJBBiJvVTeI4NhdUoFWFSkGFQm-R7TjqisUp2-2BM3-cGccJLUJcY2fyGGf8zSPfADw32hRCFZoLqwUXdVVw643hyre-mnXSqY7ikO8P5f6xeHdSnaSA23kqqxxtYjTUbe8oRr6dS0VEknqmX5394NQ1irKrqYXGdVgvckFp2vXXu4cfj6YoCyVndWy7m-PWyon6KNEL4Ta-HdlYtEpN2sZN6cY3qsFe_gty_l05eWkr2rsNtxKGZDuD0u_ANR_uwsZOQP_5-0_2gsWqzhgu34BfB1R4wd4OeRhmQss-EOZjaAj6pZ23kVGVzQP72i-Ip4EfmcWCSozYp0Rm8BLPHrqorFC0Dz2FbaOkL-ho069X7JKSoyzDDujp8CKnCO834Xhv9_ObfZ4aL3CHAGjFhZHKWuPbDr0Nm5ddqbz0VnSll845Vc7aXNbW125m0UJIKWpbK2mUU6aylS_vwVrog38AjPjuOmVLW9Sd6LzQxGMppG0dAiNpXAbPxjffnA38Gk30SyrdTOrJYHPQyTRlPL41qqhJn95582ehZPB0GsaPhjIhJvj-gubUQktcMmUG9weNTqIRA1ZaiSKD-oqupwlEyH11JMxPIzE3utYCjeDD_9_WI7iJqKsa4jhbsLZaXvjHiGxW9klavr8B3kj6Vg
  priority: 102
  providerName: ProQuest
Title Liver Disease and Other Comorbidities in Wolcott-Rallison Syndrome: Different Phenotype and Variable Associations in a Large Cohort
URI https://karger.com/doi/10.1159/000369804
https://www.ncbi.nlm.nih.gov/pubmed/25659842
https://www.proquest.com/docview/1689660909
https://search.proquest.com/docview/1674962143
https://pubmed.ncbi.nlm.nih.gov/PMC4464042
Volume 83
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1Nb9QwEB2VlgOXCtpCA2XlIsTNYjdx_NFbgVZVVQoqFPYW2Y6jrro4qGwPnPnjnXGyURfBNbbHScb2vBmPnwFeW2NzoXPDhTOCC1Xm3AVruQ51KMeN9LqhOOTHc3lyKU6n5bSPd9BZmGvKf07UqAO3ABrct4k3xWgi_tzIFUJuStLjfIim0CasSdfrTtCEcqI46mmEVloT9S8iGKNFvmKHHnbd_gtl_p0sec_6HD-GzR42ssNOz09gLcQt2D6M6DL_-M3esJTImSLk2_DnjHIt2Idu64XZWLNPBPMYzv32xs3qRKLKZpF9b-dEzcAv7HxOWUXsS89fcICtu4tTFig6xJYitUnSN_St6bQVu6fXJMuyM_o67OQKEf0OXB4ffX1_wvu7FrhHzLPgwkrtnA11gw6GmxRNoYMMTjRFkN57XYzriVQuKD92uChIKZRTWlrttS1dGYqnsB7bGHaBEcVdo13hctWIJghD1JVCutojFpLWZ_Bq-eernx2lRpVckdJUg6Yy2Ol0MlRZPt9bqqjqZ9uvaiI1kYyasclgfyjGeUKbHzaG9pbqKGFkjvAwg2edRgfRyzGRgVrR9VCBOLhXS-LsKnFxozctcN17_p_XfQGPEGGVXcxmD9YXN7fhJaKYhRvBAzVVI9h4d3T--WKUhvMdL8fv_Q
link.rule.ids 230,315,786,790,891,12083,21416,27666,27955,27956,31752,31753,33777,33778,43343,43838
linkProvider Karger AG
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwEB7BFgkuCGiBQAGDEDeru4nj2FxQgVYLbBdUWugtsh1HXXWblO32wJk_zozjDS1CXGNn8hhn_M0j3wC8NNqkQqWaC6sFF0WecuuN4cpXPh_W0qma4pB7Uzk-FB-P8qMYcDuPZZUrmxgMddU6ipFvjaQiIkk91G_OfnDqGkXZ1dhC4zqsEeWmGsDa253pl_0-ykLJWR3a7o5wa-VEfRTphXAb3wpsLFrFJm2rTenGCdVgL_4FOf-unLy0Fe3egdsRQ7LtTul34Zpv7sH6doP-8-lP9oqFqs4QLl-HXxMqvGDvuzwMM03FPhPmY2gI2oWdVYFRlc0a9r2dE08D3zfzOZUYsa-RzOA1nt11UVmiaN-0FLYNkr6ho02_XrFLSg6yDJvQ0-FFjhHeb8Dh7s7BuzGPjRe4QwC05MJIZa3xVY3ehh1ldaa89FbUmZfOOZUNq5EsrC_c0KKFkFIUtlDSKKdMbnOf3YdB0zb-ITDiu6uVzWxa1KL2QhOPpZC2cgiMpHEJvFi9-fKs49cog1-S67JXTwIbnU76KavjmysVlfHTOy__LJQEnvfD-NFQJsQ0vr2gOYXQMkWsmMCDTqO9aMSAuVYiTaC4out-AhFyXx1pZseBmBtda4FG8NH_b-sZ3Bwf7E3KyYfpp8dwCxFY3sV0NmGwXFz4J4hylvZpXMq_Adye_Uw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Liver+disease+and+other+comorbidities+in+Wolcott-Rallison+syndrome%3A+different+phenotype+and+variable+associations+in+a+large+cohort&rft.jtitle=Hormone+research+in+paediatrics&rft.au=Habeb%2C+Abdelhadi+M&rft.au=Deeb%2C+Asma&rft.au=Johnson%2C+Matthew&rft.au=Abdullah%2C+Mohammed&rft.date=2015-01-01&rft.eissn=1663-2826&rft.volume=83&rft.issue=3&rft.spage=190&rft_id=info:doi/10.1159%2F000369804&rft_id=info%3Apmid%2F25659842&rft.externalDocID=25659842
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1663-2818&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1663-2818&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1663-2818&client=summon